Analytical range LOQ [Bioanalytics]

posted by dshah – India/United Kingdom, 2021-12-21 12:03 (28 d 12:46 ago) – Posting: # 22706
Views: 324

Dear Farmacevt,

» Please advise what if the Lower limit of quantification for some of the subjects in the BE study is greater than 5% of Cmax (not for the pre-dose concentrations).

There is always possibility that few subjects may have LLOQ of more than 5% Cmax as during the method development, the assumed Cmax is higher(compared to lower Cmax in observed) in current case. If the subjects are more than 20% having 1st time point of more than 5% Cmax, then there could be an issue with your CC range, but if less than 20% – it is generally good to submit the dossier.
To prevent the scenario in future, kindly take a range of Cmax for consideration of CC range. The lower Cmax can be considered for 5 or 6 half life consideration of LLOQ and upper Cmax for ULOQ consideration.

Complete thread:

 Admin contact
21,831 posts in 4,567 threads, 1,553 registered users;
online 9 (0 registered, 9 guests [including 4 identified bots]).
Forum time: Wednesday 00:50 CET (Europe/Vienna)

Research under a paradigm must be a particularly effective way
of inducing paradigm change.    Thomas S. Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz